Here's the live share price of Orchid Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Orchid Pharma has gained 111.96% CAGR. Over the past year, the corresponding return has been -46.86%.
Orchid Pharma’s current P/E of 45.84x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Orchid Pharma | 6.91 | 7.00 | -0.90 | -3.01 | -46.86 | 26.13 | 111.96 |
| Sun Pharmaceutical Industries | 0.21 | 4.09 | 4.55 | -6.87 | -8.37 | 18.13 | 29.41 |
| Divi's Laboratories | 3.01 | 18.83 | 6.72 | 11.24 | 15.00 | 20.95 | 17.36 |
| Torrent Pharmaceuticals | 1.13 | 1.56 | -1.51 | 11.14 | 12.82 | 28.97 | 23.26 |
| Cipla | -4.56 | -0.15 | 0.69 | -0.92 | -3.05 | 8.78 | 15.02 |
| Dr. Reddy's Laboratories | -6.82 | -4.00 | -1.90 | 1.15 | -4.93 | 9.63 | 4.26 |
| Mankind Pharma | -1.10 | -1.38 | -6.14 | 0.97 | -10.61 | 19.09 | 11.05 |
| Zydus Lifesciences | -2.48 | -1.11 | 3.35 | 10.76 | -2.32 | 31.30 | 19.05 |
| Lupin | 2.82 | 0.21 | 6.45 | -3.50 | -9.66 | 41.03 | 16.84 |
| Alkem Laboratories | 1.43 | 3.02 | 14.92 | 10.89 | -3.15 | 20.35 | 16.18 |
| Aurobindo Pharma | 6.46 | 6.27 | 7.00 | -4.69 | -17.55 | 28.09 | 8.74 |
| Abbott India | -2.87 | -2.64 | -13.64 | -5.43 | -0.77 | 13.95 | 13.40 |
| Glenmark Pharmaceuticals | 4.15 | -3.30 | -8.37 | 37.68 | 12.01 | 66.11 | 31.97 |
| Laurus Labs | 5.39 | 11.82 | 14.99 | 57.19 | 95.23 | 27.49 | 26.52 |
| Biocon | 5.25 | 9.09 | -1.29 | 18.63 | 18.91 | 11.88 | -1.32 |
| GlaxoSmithKline Pharmaceuticals | -2.38 | -0.36 | -8.49 | -5.88 | -1.64 | 24.87 | 13.76 |
| Anthem Biosciences | -2.34 | -8.90 | -4.74 | -3.74 | -3.74 | -1.26 | -0.76 |
| Ipca Laboratories | 3.31 | -1.35 | -9.79 | -4.97 | -18.56 | 12.27 | 2.64 |
| Gland Pharma | 1.53 | -0.57 | -0.50 | 40.19 | 19.72 | 3.29 | 1.58 |
| Ajanta Pharma | 5.14 | 5.79 | -5.82 | -1.81 | -17.59 | 24.26 | 19.30 |
Over the last one year, Orchid Pharma has declined 46.86% compared to peers like Sun Pharmaceutical Industries (-8.37%), Divi's Laboratories (15.00%), Torrent Pharmaceuticals (12.82%). From a 5 year perspective, Orchid Pharma has outperformed peers relative to Sun Pharmaceutical Industries (29.41%) and Divi's Laboratories (17.36%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 713.12 | 717.16 |
| 10 | 718.72 | 718.64 |
| 20 | 725.64 | 722.28 |
| 50 | 730.94 | 729.22 |
| 100 | 730.37 | 758.58 |
| 200 | 847.87 | 854.76 |
In the latest quarter, Orchid Pharma remained same as its previous close in promoter holding, while DII stake decreased to 19.04%, FII holding rose to 1.56%, and public shareholding moved up to 9.57% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 34,65,947 | 0.83 | 243.31 | |
| 10,44,216 | 0.38 | 73.3 | |
| 7,45,230 | 0.54 | 52.32 | |
| 4,92,727 | 0.43 | 34.59 | |
| 1,53,202 | 0.39 | 10.75 | |
| 1,00,000 | 0.64 | 7.02 | |
| 31,617 | 0.13 | 2.22 | |
| 2,369 | 0.01 | 0.17 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 30, 2025, 10:48 PM IST | Orchid Pharma - Update On Purchase Of Assets Of Allecra Therapeutics Gmbh |
| Oct 10, 2025, 10:42 PM IST | Orchid Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 22, 2025, 11:44 PM IST | Orchid Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 20, 2025, 11:10 PM IST | Orchid Pharma - Announcement under Regulation 30 (LODR)-Meeting Updates |
| Sep 20, 2025, 10:55 PM IST | Orchid Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM |
Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 921.93 Cr. and Equity Capital is Rs. 50.72 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Orchid Pharma is ₹770.10 as on Nov 03, 2025.
The Orchid Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Orchid Pharma is ₹3,905.88 Cr as on Nov 03, 2025.
Today’s highest and lowest price of Orchid Pharma are ₹800.60 and ₹720.00.
The 52-week high/low is the highest and lowest price at which Orchid Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Orchid Pharma is ₹1,998.00 and 52-week low of Orchid Pharma is ₹603.80 as on Nov 03, 2025.
The Orchid Pharma has shown returns of 6.09% over the past day, 7.0% for the past month, -0.9% over 3 months, -46.86% over 1 year, 26.13% across 3 years, and 111.96% over 5 years.
P/E ratio of and PB ratio of Orchid Pharma are 45.84 and 3.19 on Nov 03, 2025. While the company gives a dividend yield of 0.00 per annum.